News • Pharma Industry

malaria: Why the approval of the first malaria vaccine is a milestone in the fight against killer parasites

2 years ago

[ad_1]

A municipal corporation of Delhi worker seen fumigating a residential area as a precautionary measure to stop the spread of Malaria on September 8, 2020.

Synopsis

Microbiologists had been trying in vain for years to develop vaccines that would prevent infection or reinfection of parasitic diseases. Which is why WHO’s nod to Mosquirix marks a watershed in the fight against not just the mosquito-borne disease, but scores of other tropical diseases. The malaria vaccine proves it’s finally possible to tackle such diseases.

Adam PioreMalaria sickened 241 million people and killed roughly 627,000. In sub-Saharan Africa, where 95% of cases and deaths took place, children under five accounted for 80% of the fatalities.The numbers are horrifying—but there is finally a reason for optimism. Last October, the World Health Organization approved GlaxoSmithKline’s malaria vaccine, known as RTS,S or Mosquirix. It’s the world’s first vaccine for the deadly disease, which is

BY

MIT

  • GIFT ARTICLE
  • FONT SIZE

    AbcSmall

    AbcMedium

    AbcLarge

  • SAVE
  • PRINT
  • COMMENT

Why ?

  • Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors

  • Stock analysis. Market Research. Industry Trends on 4000+ Stocks

  • Clean experience with
    Minimal Ads

  • Comment & Engage with ET Prime community

  • Exclusive invites to Virtual Events with Industry Leaders

  • A trusted team of Journalists & Analysts who can best filter signal from noise

[ad_2]

Source link

You may also like

Subscribe Our Newsletter for regular updates!

[mailpoet_form id="1"]